OptimizeRx Corporation (OPRX)

OptimizeRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24.1	23.37	13.38	13.85	18.21	84.68
Short-Term Investments	-	-	-	-	55.93	-
Cash & Short-Term Investments	24.1	23.37	13.38	13.85	74.14	84.68
Cash Growth	45.29%	74.63%	-3.41%	-81.32%	-12.45%	705.21%
Accounts Receivable	24.8	37.75	38.21	36.25	22.16	24.8
Other Receivables	2.33	0.75	-	1.04	-	-
Receivables	27.12	38.5	38.21	37.29	22.16	24.8
Prepaid Expenses	2.93	1.21	0.77	1.29	0.85	0.93
Other Current Assets	-	1.64	1.61	1.9	1.43	4.7
Total Current Assets	54.15	64.72	53.97	54.33	98.58	115.11
Property, Plant & Equipment	0.57	0.51	0.52	0.72	0.37	0.47
Goodwill	70.87	70.87	70.87	78.36	22.67	14.74
Other Intangible Assets	38.71	40.8	45.52	49.4	13.02	10.65
Other Long-Term Assets	0.02	0.03	0.3	0.57	0.01	0.01
Total Assets	164.32	176.92	171.17	183.37	134.65	140.99

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.32	1.64	2.16	2.23	1.55	0.61
Accrued Expenses	5.39	11.59	8.49	7.71	2.6	2.9
Current Portion of Long-Term Debt	1.25	4.26	2	2	-	-
Current Portion of Leases	0.23	0.19	0.17	0.22	0.09	0.09
Current Income Taxes Payable	-	-	0.32	0.05	-	-
Current Unearned Revenue	0.71	0.5	0.47	0.17	0.16	1.39
Other Current Liabilities	0.81	3.09	5.05	5.51	3.99	4.38
Total Current Liabilities	9.71	21.26	18.65	17.88	8.4	9.37
Long-Term Debt	17.76	21.42	30.82	34.23	-	-
Long-Term Leases	0.25	0.23	0.21	0.37	0.14	0.24
Long-Term Deferred Tax Liabilities	5.52	5.71	4.49	4.34	-	-
Total Liabilities	33.24	48.62	54.17	56.82	8.54	9.61

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	211.49	207.51	201.35	190.79	172.79	166.62
Retained Earnings	-80.43	-79.24	-84.37	-64.26	-46.69	-35.25
Treasury Stock	-0	-0	-0	-0	-0	-
Comprehensive Income & Other	0.01	-	-	-	-	-
Shareholders' Equity	131.08	128.29	117	126.55	126.11	131.38
Total Liabilities & Equity	164.32	176.92	171.17	183.37	134.65	140.99

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	19.48	26.1	33.19	36.82	0.23	0.33
Net Cash (Debt)	4.62	-2.74	-19.81	-22.97	73.91	84.35
Net Cash Growth	-	-	-	-	-12.39%	737.84%
Net Cash Per Share	0.24	-0.14	-1.08	-1.34	4.16	4.77
Filing Date Shares Outstanding	18.84	18.76	18.49	18.18	17.1	17.88
Total Common Shares Outstanding	18.83	18.76	18.45	18.16	17.07	17.86
Working Capital	44.44	43.45	35.32	36.45	90.18	105.74
Book Value Per Share	6.96	6.84	6.34	6.97	7.39	7.36
Tangible Book Value	21.5	16.63	0.61	-1.2	90.41	105.99
Tangible Book Value Per Share	1.14	0.89	0.03	-0.07	5.30	5.93
Machinery	-	0.46	0.41	0.3	0.27	0.47

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error